Detalhe da pesquisa
1.
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective.
Br J Cancer
; 130(6): 897-907, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191608
2.
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019.
BJU Int
; 131(6): 734-744, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36680312
3.
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 650-658, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421369
4.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411939
5.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578639
6.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
; 387(10024): 1163-77, 2016 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719232
7.
ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer.
Invest New Drugs
; 35(5): 599-607, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28144789
8.
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279).
BJU Int
; 116(6): 880-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639506
9.
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
Lancet Oncol
; 13(5): 549-58, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22452894
10.
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.
J Clin Oncol
; 41(1): 54-64, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960902
11.
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.
Eur Urol
; 84(1): 49-64, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967359
12.
A systematic review of disease related stigmatization in patients living with prostate cancer.
PLoS One
; 17(2): e0261557, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148315
13.
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial.
Eur Urol
; 82(5): 512-515, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688662
14.
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
JNCI Cancer Spectr
; 6(4)2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877084
15.
Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID).
J Clin Oncol
; 39(3): 190-201, 2021 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326257
16.
Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents.
Clin Genitourin Cancer
; 16(4): e777-e784, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550200
17.
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Eur Urol Oncol
; 1(6): 449-458, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158087
18.
Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial.
BJU Int
; 110(7): 919-21, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22882350
19.
Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC).
Trials
; 18(1): 327, 2017 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716064
20.
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy.
Int J Radiat Oncol Biol Phys
; 96(1): 78-86, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511849